Literature DB >> 27927987

Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes.

David C Bode1, Mark D Baker2, John H Viles3.   

Abstract

A central hallmark of Alzheimer's disease is the presence of extracellular amyloid plaques chiefly consisting of amyloid-β (Aβ) peptides in the brain interstitium. Aβ largely exists in two isoforms, 40 and 42 amino acids long, but a large body of evidence points to Aβ(1-42) rather than Aβ(1-40) as the cytotoxic form. One proposed mechanism by which Aβ exerts toxicity is the formation of ion channel pores that disrupt intracellular Ca2+ homeostasis. However, previous studies using membrane mimetics have not identified any notable difference in the channel forming properties between Aβ(1-40) and Aβ(1-42). Here, we tested whether a more physiological environment, membranes excised from HEK293 cells of neuronal origin, would reveal differences in the relative channel forming ability of monomeric, oligomeric, and fibrillar forms of both Aβ(1-40) and Aβ(1-42). Aβ preparations were characterized with transmission electron microscopy and thioflavin T fluorescence. Aβ was then exposed to the extracellular face of excised membranes, and transmembrane currents were monitored using patch clamp. Our data indicated that Aβ(1-42) assemblies in oligomeric preparations form voltage-independent, non-selective ion channels. In contrast, Aβ(1-40) oligomers, fibers, and monomers did not form channels. Ion channel conductance results suggested that Aβ(1-42) oligomers, but not monomers and fibers, formed three distinct pore structures with 1.7-, 2.1-, and 2.4-nm pore diameters. Our findings demonstrate that only Aβ(1-42) contains unique structural features that facilitate membrane insertion and channel formation, now aligning ion channel formation with the differential neurotoxic effect of Aβ(1-40) and Aβ(1-42) in Alzheimer's disease.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Alzheimer's disease; Aβ; amyloid-β; ion channel; membrane; oligomer; pore; toxicity

Mesh:

Substances:

Year:  2016        PMID: 27927987      PMCID: PMC5270483          DOI: 10.1074/jbc.M116.762526

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red.

Authors:  Y Hirakura; M C Lin; B L Kagan
Journal:  J Neurosci Res       Date:  1999-08-15       Impact factor: 4.164

2.  Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Authors:  Dominic M Walsh; Igor Klyubin; Julia V Fadeeva; William K Cullen; Roger Anwyl; Michael S Wolfe; Michael J Rowan; Dennis J Selkoe
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

3.  Diversity of amyloid beta protein fragment [1-40]-formed channels.

Authors:  J I Kourie; C L Henry; P Farrelly
Journal:  Cell Mol Neurobiol       Date:  2001-06       Impact factor: 5.046

4.  Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

Authors:  J Näslund; V Haroutunian; R Mohs; K L Davis; P Davies; P Greengard; J D Buxbaum
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

5.  Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

Authors:  H Lin; R Bhatia; R Lal
Journal:  FASEB J       Date:  2001-11       Impact factor: 5.191

6.  Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex.

Authors:  A M Klein; N W Kowall; R J Ferrante
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

7.  Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease.

Authors:  R Mayeux; M X Tang; D M Jacobs; J Manly; K Bell; C Merchant; S A Small; Y Stern; H M Wisniewski; P D Mehta
Journal:  Ann Neurol       Date:  1999-09       Impact factor: 10.422

8.  Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles.

Authors:  H Lin; Y J Zhu; R Lal
Journal:  Biochemistry       Date:  1999-08-24       Impact factor: 3.162

9.  Neurodegenerative disease: amyloid pores from pathogenic mutations.

Authors:  Hilal A Lashuel; Dean Hartley; Benjamin M Petre; Thomas Walz; Peter T Lansbury
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

10.  Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

Authors:  Karie N Dahlgren; Arlene M Manelli; W Blaine Stine; Lorinda K Baker; Grant A Krafft; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

View more
  46 in total

1.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

2.  Amyloid-β oligomers have a profound detergent-like effect on lipid membrane bilayers, imaged by atomic force and electron microscopy.

Authors:  David C Bode; Mark Freeley; Jon Nield; Matteo Palma; John H Viles
Journal:  J Biol Chem       Date:  2019-04-03       Impact factor: 5.157

3.  Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells.

Authors:  Dominic D Quintana; Jorge A Garcia; Yamini Anantula; Stephanie L Rellick; Elizabeth B Engler-Chiurazzi; Saumyendra N Sarkar; Candice M Brown; James W Simpkins
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  Evidence for aggregation-independent, PrPC-mediated Aβ cellular internalization.

Authors:  Alejandro R Foley; Graham P Roseman; Ka Chan; Amanda Smart; Thomas S Finn; Kevin Yang; R Scott Lokey; Glenn L Millhauser; Jevgenij A Raskatov
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

Review 5.  Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

Authors:  Vijayaraghavan Rangachari; Dexter N Dean; Pratip Rana; Ashwin Vaidya; Preetam Ghosh
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-09       Impact factor: 3.747

6.  Depletion of NK Cells Improves Cognitive Function in the Alzheimer Disease Mouse Model.

Authors:  Yuanyue Zhang; Ivan Ting Hin Fung; Poornima Sankar; Xiangyu Chen; Lisa S Robison; Longyun Ye; Shanti S D'Souza; Abigail E Salinero; Marcy L Kuentzel; Sridar V Chittur; Wenzheng Zhang; Kristen L Zuloaga; Qi Yang
Journal:  J Immunol       Date:  2020-06-05       Impact factor: 5.422

7.  Endocytosis Is a Key Mode of Interaction between Extracellular β-Amyloid and the Cell Membrane.

Authors:  Jing-Ming Shi; Li Zhu; Xi Lan; Duan-Wei Zhao; Yong-Jun He; Zheng-Qi Sun; Di Wu; Hai-Yun Li
Journal:  Biophys J       Date:  2020-08-15       Impact factor: 4.033

8.  Cholesterol-rich naked mole-rat brain lipid membranes are susceptible to amyloid beta-induced damage in vitro.

Authors:  Daniel Frankel; Matthew Davies; Bharat Bhushan; Yavuz Kulaberoglu; Paulina Urriola-Munoz; Justine Bertrand-Michel; Melissa R Pergande; Andrew A Smith; Swapan Preet; Thomas J Park; Michele Vendruscolo; Kenneth S Rankin; Stephanie M Cologna; Janet R Kumita; Nicolas Cenac; Ewan St John Smith
Journal:  Aging (Albany NY)       Date:  2020-11-04       Impact factor: 5.682

9.  Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a Drosophila model of Alzheimer's disease.

Authors:  Nadine D Younan; Ko-Fan Chen; Ruth-Sarah Rose; Damian C Crowther; John H Viles
Journal:  J Biol Chem       Date:  2018-06-10       Impact factor: 5.157

Review 10.  Mamma Mia, P-glycoprotein binds again.

Authors:  Richard Callaghan; Ingrid C Gelissen; Anthony M George; Anika M S Hartz
Journal:  FEBS Lett       Date:  2020-10-20       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.